Literature DB >> 11981273

Prostate cancer update.

Brian I Rini1, Eric J Small.   

Abstract

Recent advances in prostate cancer have focused on treatment strategies in patients with biochemical relapse and novel methods of androgen deprivation therapy such as intermittent therapy, the role of bisphosphonates, and immunotherapeutic approaches. Continued investigation into the mechanism of androgen independence and effective treatments for hormone-refractory disease are described. This article reviews the major advances in prostate cancer published between November 1, 2000, and October 31, 2001.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11981273     DOI: 10.1097/00001622-200205000-00006

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  2 in total

1.  A mathematical investigation of the multiple pathways to recurrent prostate cancer: comparison with experimental data.

Authors:  Trachette L Jackson
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

2.  Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3.

Authors:  Saeed Samarghandian; Jalil Tavakkol Afshari; Saeideh Davoodi
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.